- Portable Blood Gas Analyzers
- Desktop Blood Gas Analyzers
Blood Gas Analyzers Market size is accounted for USD 765.5 million in 2022 and is poised to grow at a CAGR of 5.2% from 2023 to 2029. Blood gas analysis has proven to be an effective diagnostic technique in critical care, pre-hospital and in-hospital emergency treatment. With the advent sensor technology, blood gas testing has become more accessible to patients. Respiratory therapists play a vital role for blood gas analysis at its center. Surge in the demand for technology-integrated systems and point-of-care devices is anticipated to fuel the blood gas analyzers market. Blood gas analyzers are the analytical instruments that are used in measuring the blood gas (pCO2 and pO2), electrolytes, metabolites, and the combinations opH from the blood samples. The conservation of blood is the major initiative in the clinical diagnostic lab, which need an accurate blood gas analyzer that can streamline the process of work and help in reduction of the errors with minimal maintenance. Blood gas analyzers are available in a lightweight and in small footprint design. Most models offer simple replacement of the solutions for the analysis such as solution packs and sensor cassettes. There are certain unique features to some of the blood gas analyzers such as liquid calibration which replaces previously required regulators, humidifiers, tubing lines and gas tanks.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increased prevalence of chronic diseases such as diabetes and other cardiovascular disorders is expected to increase the demand for blood gas analyzers. Surge in the prevalence of chronic diseases due to aging population and socioeconomic changes are contributing to long-term health issues. Sedentary lifestyle coupled with dramatic changes in the dietary habits are major factors, which drives the prevalence of diabetic population. Moreover, increased obesity rates lead to multiple chronic disorders. In accordance with World Health Organization (WHO), chronic disease prevalence is anticipated to climb by 57 percent by 2020. However, high cost of analyzers and limited reimbursement are inhibiting the market growth.
North America blood gas analyzers market has registered the highest revenue share in 2021 and is expected to continue its dominance in the future. The demand for blood gas analyzers is expected to boost due to presence of sophisticated domestic and international medical device manufacturers in the region. Furthermore, medical tourism is expected to attract the patients from all over the world due to presence of state-of-art healthcare infrastructure in The inclination towards Point-of-Care devices is expected to fuel the demand for PoC Blood gas analyzers in the future. Europe is predicted to have a considerable market share during the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
The key segments covered in the blood gas analyzers market are: by product, application, and geography
The blood gas analyzers market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The blood gas analyzers market key players are: Abbott Laboratories, Danaher Corporation (Radiometer), Hoffmann-La Roche AG, IDEXX Laboratories,Inc. (OptiMedicalSystems,Inc.), Medica Corporation, Nova Biomedical